Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration

被引:30
|
作者
Guo, Yu-Chien [1 ]
Chiu, Yun-Hsuan [1 ]
Chen, Chie-Pein [2 ]
Wang, Hwai-Shi [1 ]
机构
[1] Natl Yang Ming Univ, Inst Anat & Cell Biol, Sch Med, Taipei 112, Taiwan
[2] Mackay Mem Hosp, Div High Risk Pregnancy, Taipei, Taiwan
来源
STEM CELL RESEARCH & THERAPY | 2018年 / 9卷
关键词
Interleukin-1; Umbilical cord mesenchymal stem cell; CXCR3; CXCL9; Transendothelial migration; ENDOTHELIAL-CELLS; P38; MAPK; T-CELLS; CXCR3; EXPRESSION; TRANSMIGRATE; ACTIVATION; IL-1-BETA; INHIBITION; CYTOKINES;
D O I
10.1186/s13287-018-1032-9
中图分类号
Q813 [细胞工程];
学科分类号
摘要
BackgroundMesenchymal stem cells (MSCs) are known to home to injured and inflamed regions via the bloodstream to assist in tissue regeneration in response to signals of cellular damage. However, the factors and mechanisms that affect their transendothelial migration are still unclear. In this study, the mechanisms involved in interleukin-1 (IL-1) enhancing the transendothelial migration of MSCs were investigated.MethodsImmunofluorescence staining and Western blotting were used to observe IL-1-induced CXC chemokine receptor 3 (CXCR3) expression on MSCs. Quantitative real-time PCR and ELISA were used to demonstrate IL-1 upregulated both chemokine (C-X-C motif) ligand 9 (CXCL9) mRNA and CXCL9 ligand secretion in human umbilical vein endothelial cells (HUVECs). Monolayer co-cultivation, agarose drop chemotaxis, and transwell assay were conducted to investigate the chemotaxis invasion and transendothelial migration ability of IL-1-induced MSCs in response to CXCL9.ResultsIn this study, our immunofluorescence staining showed that IL-1 induces CXCR3 expression on MSCs. This result was confirmed by Western blotting. Following pretreatment with protein synthesis inhibitor cycloheximide, we found that IL-1 induced CXCR3 on the surface of MSCs via protein synthesis pathway. Quantitative real-time PCR and ELISA validated that IL-1 upregulated both CXCL9 mRNA and CXCL9 ligand secretion in HUVECs. In response to CXCL9, chemotaxis invasion and transendothelial migration ability were increased in IL-1-stimulated MSCs. In addition, we pretreated MSCs with CXCR3 antagonist AMG-487 and p38 MAPK inhibitor SB203580 to confirm CXCR3-CXCL9 interaction and the role of CXCR3 in IL-1-induced chemotaxis invasion and transendothelial migration.ConclusionWe found that IL-1 induces the expression of CXCR3 through p38 MAPK signaling and that IL-1 also enhances CXCL9 ligand secretion in HUVECs. These results indicated that IL-1 promotes the transendothelial migration of MSCs through CXCR3-CXCL9 axis. The implication of the finding could enhance the efficacy of MSCs homing to target sites.
引用
收藏
页数:15
相关论文
共 50 条
  • [11] CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor
    Dar, Wasim A.
    Knechtle, Stuart J.
    IMMUNOLOGY, 2007, 120 (04) : 467 - 485
  • [12] Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration
    Krstic, Jelena
    Obradovic, Hristina
    Jaukovic, Aleksandra
    Okic-Dordevic, Ivana
    Trivanovic, Drenka
    Kukolj, Tamara
    Mojsilovic, Slavko
    Ilic, Vesna
    Santibanez, Juan F.
    Bugarski, Diana
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2015, 1853 (02): : 431 - 444
  • [13] Interleukin-1α induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells
    Cheng, Jiwen
    Li, Ling
    Liu, Yan
    Wang, Zhirou
    Zhu, Xiaodong
    Bai, Xianzhong
    MOLECULAR MEDICINE REPORTS, 2012, 6 (05) : 955 - 960
  • [14] Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor
    Halpern, Jennifer L.
    Kilbarger, Amy
    Lynch, Conor C.
    CANCER LETTERS, 2011, 308 (01) : 91 - 99
  • [15] Tumor Necrosis Factor Receptor 1 Is Required for Human Umbilical Cord-Derived Mesenchymal Stem Cell-Mediated Rheumatoid Arthritis Therapy
    Liu, Guangyang
    Wang, Herui
    Zhang, Chenliang
    Li, Xin
    Mi, Yi
    Chen, Yaoyao
    Xu, Liqiang
    Miao, Li
    Long, Haomiao
    Liu, Yongjun
    CELL TRANSPLANTATION, 2025, 34
  • [16] Combined mesenchymal stem cell transplantation and interleukin-1 receptor antagonism after partial hepatectomy
    Sang, Jian-Feng
    Shi, Xiao-Lei
    Han, Bing
    Huang, Xu
    Huang, Tao
    Ren, Hao-Zhen
    Ding, Yi-Tao
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (16) : 4120 - 4135
  • [17] AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells
    Greco, Steven J.
    Patel, Shyam A.
    Bryan, Margarette
    Pliner, Lillian F.
    Banerjee, Debabrata
    Rameshwar, Pranela
    AMERICAN JOURNAL OF CANCER RESEARCH, 2011, 1 (06): : 701 - S4
  • [18] Cell-to-Cell Culture Inhibits Dedifferentiation of Chondrocytes and Induces Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells
    Li, Xingfu
    Liang, Yujie
    Xu, Xiao
    Xiong, Jianyi
    Ouyang, Kan
    Duan, Li
    Wang, Daping
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [19] Adenovector-Mediated Gene Delivery to Human Umbilical Cord Mesenchymal Stromal Cells Induces Inner Ear Cell Phenotype
    Devarajan, Keerthana
    Forrest, M. Laird
    Detamore, Michael S.
    Staecker, Hinrich
    CELLULAR REPROGRAMMING, 2013, 15 (01) : 43 - 54
  • [20] Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity
    Chatterjee, Debanjana
    Marquardt, Nicole
    Tufa, Dejene Milkessa
    Beauclair, Guillaume
    Low, Hui Zhi
    Hatlapatka, Tim
    Hass, Ralf
    Kasper, Cornelia
    von Kaisenberg, Constantin
    Schmidt, Reinhold Ernst
    Jacobs, Roland
    CELL COMMUNICATION AND SIGNALING, 2014, 12